Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

30.7K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
30.7K
Lipid Catabolism01:25

Lipid Catabolism

22
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
22
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

96
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
96
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

256
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
256
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

95
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
95
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

1.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multisystem Mucosal Morbidity in Recessive Dystrophic Epidermolysis Bullosa Inversa.

Pediatric dermatology·2026
Same author

Re: Pegvaliase Treatment for Adolescents With Phenylketonuria: A Multi-Site Study.

JIMD reports·2026
Same author

Impacts of genetic counseling on hypophosphatasia heterozygotes identified through carrier screening.

Journal of genetic counseling·2026
Same author

Analysis of purines and pyrimidines across biospecimens: influence of storage temperature and duration.

Scientific reports·2026
Same author

<i>COASY</i>-Associated Disorders as a Differential Diagnosis in Cases with Newborn Screening Results Suggestive of CPT-I.

International journal of neonatal screening·2026
Same author

Biochemical genetic testing for congenital disorders of glycosylation after sequencing produces equivocal results.

Molecular genetics and metabolism·2026

Related Experiment Video

Updated: Jul 12, 2025

Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide
07:34

Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide

Published on: May 12, 2023

1.1K

Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency: Family Impact and Perspectives.

Sarah Crawford1, Elizabeth Sablon2, Nadia Ali2

  • 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.

International Journal of Neonatal Screening
|October 24, 2023
PubMed
Summary

Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCADD) diagnosis impacts families, creating challenges with medical diets and access to care. Financial and work barriers are significant for families managing this fatty acid oxidation disorder.

Keywords:
VLCADDbarrierscardiomyopathycaregivermedical dietmetabolismrhabdomyolysis

More Related Videos

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

931
A Fluorescence-based Assay for Characterization and Quantification of Lipid Droplet Formation in Human Intestinal Organoids
10:12

A Fluorescence-based Assay for Characterization and Quantification of Lipid Droplet Formation in Human Intestinal Organoids

Published on: October 13, 2019

9.1K

Related Experiment Videos

Last Updated: Jul 12, 2025

Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide
07:34

Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide

Published on: May 12, 2023

1.1K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

931
A Fluorescence-based Assay for Characterization and Quantification of Lipid Droplet Formation in Human Intestinal Organoids
10:12

A Fluorescence-based Assay for Characterization and Quantification of Lipid Droplet Formation in Human Intestinal Organoids

Published on: October 13, 2019

9.1K

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCADD) is a genetic disorder affecting fatty acid metabolism.
  • It impairs the breakdown of long-chain fatty acids, leading to potential health issues like rhabdomyolysis and cardiomyopathy.
  • Current management involves dietary modifications and preventing fasting.

Purpose of the Study:

  • To evaluate the impact of a VLCADD diagnosis on family dynamics.
  • To identify barriers to care and challenges related to medical nutrition therapy.
  • To assess clinical outcomes in patients with VLCADD over a 5-year period.

Main Methods:

  • A survey was administered to 10 caregivers of individuals with VLCADD.
  • Clinical outcomes of 11 patients diagnosed with VLCADD were reviewed.
  • Data collected included patient symptoms and caregiver-reported family impacts.

Main Results:

  • Families reported significant barriers related to finances, work limitations, and accessing appropriate nutrition.
  • Patients experienced clinical manifestations including rhabdomyolysis, cardiomyopathy, and hospitalizations.
  • The diagnosis necessitates substantial lifestyle and dietary adjustments for affected families.

Conclusions:

  • The diagnosis of VLCADD presents considerable challenges for families beyond the direct medical care of the patient.
  • Addressing financial, employment, and nutritional access barriers is crucial for comprehensive VLCADD management.
  • Further research is needed to support families navigating the complexities of this metabolic disorder.